| Annual · values | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -16.83 M USD | -21.72 M USD | -20.67 M USD | -17.89 M USD | -11.47 M USD | -12.59 M USD | -14.81 M USD | -14.77 M USD | -22.46 M USD | -26.75 M USD | -25.18 M USD | -15.32 M USD |
| Depreciation & Amortization | 333000 USD | 494000 USD | 239000 USD | 202000 USD | 266000 USD | 285000 USD | 321000 USD | 463000 USD | 642000 USD | 696000 USD | 438000 USD | 111000 USD |
| Stock-Based Compensation | 743000 USD | 1.28 M USD | 1.33 M USD | 993000 USD | 833000 USD | 749000 USD | 1.11 M USD | 2.77 M USD | 3.65 M USD | 3.40 M USD | 2.35 M USD | 5.18 M USD |
| Capital Expenditures | 16000 USD | 0 USD | 81000 USD | 25000 USD | 47000 USD | 73000 USD | 22000 USD | 13000 USD | 21000 USD | 452000 USD | 584000 USD | 169000 USD |
| Cash Flow from Investing | -16000 USD | 0 USD | -18.15 M USD | -25000 USD | -47000 USD | -73000 USD | -22000 USD | -13000 USD | -21000 USD | -437000 USD | 1.08 M USD | -1.84 M USD |
| Cash Flow from Financing | 12.20 M USD | 0 USD | -992000 USD | -2.50 M USD | 79.51 M USD | 16.72 M USD | 21.48 M USD | 9.71 M USD | 13.41 M USD | 33.78 M USD | 137000 USD | 50.12 M USD |
| Dividends Paid | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock Buybacks | 0 USD | 0 USD | -992000 USD | -2.50 M USD | 0 USD | — | — | — | — | — | — | — |
| Free Cash Flow | -16.84 M USD | -21.72 M USD | -20.75 M USD | -17.92 M USD | -11.52 M USD | -12.66 M USD | -14.84 M USD | -14.79 M USD | -22.48 M USD | -27.20 M USD | -25.76 M USD | -15.49 M USD |
Lifeward Ltd. is a medical technology company specializing in solutions for physical rehabilitation and mobility. The company designs, develops, and markets wearable robotic exoskeletons that provide powered hip and knee motion, enabling individuals with spinal cord injuries to stand, walk, turn, and navigate stairs in clinical, home, and community settings. Lifeward’s portfolio extends beyond exoskeletons to include technologies such as anti-gravity treadmills, functional electrical stimulation systems, and soft exo-suits, all aimed at improving gait training, strength, and functional independence during recovery and long-term care. These products are used by rehabilitation hospitals, outpatient clinics, and patients at home, integrating into multidisciplinary therapy programs. Headquartered in Hudson, Massachusetts, Lifeward operates within the broader medical device and rehabilitation equipment sectors, serving neurologic, orthopedic, and general rehabilitation markets. The company plays a specialized role in enabling advanced, technology-assisted rehabilitation and mobility support for individuals with significant walking impairments.